Since both of these genes are involved in AML leukemogenesis [69–71], we concluded that G9a/GLP histone methyltransferases could have an important role in restricting expression of these oncogenes by forming the AML-specific H3K9me2 blocks. The gene discussed is EHMT2; the disease is acute myeloid leukemia.